MEDS:NASDAQ
DataMeds AI Inc
$3.76
arrow_downward
-1.31%(-0.050) 1D
Sep 29, 2:01:23 PM GMT-4 · USD
search
All symbols
No data
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MEDS...
Open
$3.90
High
$3.96
Low
$3.60
Mkt. cap
12.02M
Avg. vol.
10.98M
Volume
1.17M
52-wk high
$12.31
52-wk low
$0.82
EPS
-$48.32
Shares outstanding
3.20M
No. of employees
31
Open
$3.90
High
$3.96
Low
$3.60
Mkt. cap
12.02M
Avg. vol.
10.98M
Volume
1.17M
52-wk high
$12.31
52-wk low
$0.82
EPS
-$48.32
Shares outstanding
3.20M
No. of employees
31
News stories
From web sources and news partners
Benzinga
·
1 day ago
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga
·
1 day ago
DataMeds AI Stock Surges on Mobile App Launch
Timothy Sykes
·
1 day ago
MEDS Stock Soars As AI Oncology Bet Ignites Trading Frenzy
StocksToTrade
·
1 day ago
MEDS Stock Rockets As DataMEDS AI Bets Big On Cancer Diagnostics
About DataMeds AI Inc
CEO-
Employees31
Founded2022
HeadquartersTampa, Florida, United States
SectorHealth care provider
Websitedatamedsai.com
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
No analyst ratings found. | |||||
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 3.01M | 1.67M | 1.56M | 1.78M |
Cost of goods sold | 2.78M | 9.53M | 1.39M | 1.60M |
Cost of revenue | 2.78M | 9.53M | 1.39M | 1.60M |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 30.98M | 4.14M | 5.83M | 7.17M |
Operating expense | 31.78M | 4.94M | 6.19M | 7.53M |
Total operating expenses | 34.56M | 14.47M | 7.58M | 9.12M |
Operating income | -31.55M | -12.80M | -6.02M | -7.35M |
Other non operating income | 9.10K | 9.04K | 98.74K | -255.24K |
EBT including unusual items | -34.32M | -27.85M | -7.74M | -18.36M |
EBT excluding unusual items | -32.96M | -13.66M | -7.99M | -9.16M |
Income tax expense | - | - | - | - |
Effective tax rate | - | - | - | - |
Other operating expenses | - | - | - | - |
Net income | -34.32M | -27.85M | -7.74M | -18.36M |
Net profit margin | -1,139.04% | -1,667.19% | -496.46% | -1,031.72% |
Earnings per share | - | - | - | - |
Interest and investment income | - | - | - | - |
Interest expense | -1.43M | -875.72K | -2.07M | -1.56M |
Net interest expenses | -1.43M | -875.72K | -2.07M | -1.56M |
Depreciation and amortization charges | 802.79K | 802.60K | 356.82K | 356.60K |
EBITDA | -30.75M | -12.00M | -5.66M | -6.99M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1